| Financial Year |
March 31 2023 |
| Monetary Funds |
496,087,473.36 |
| Held-for-trading Financial Assets |
22,521,820.54 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,374,858,649.35 |
| Advances to Suppliers |
101,691,789.31 |
| Other Receivables |
103,617,426.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,737,676,411.47 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
45,648,685.70 |
| Total Current Assets |
3,882,102,255.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
77,122,074.51 |
| Investment Properties |
36,393,849.21 |
| Fixed Assetes |
2,453,761,592.82 |
| Under-construction Projects |
171,397,053.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
175,594,148.60 |
| R&D expenses |
-- |
| Goodwill |
287,621,431.58 |
| Long-Term Deferred and Prepaid Expenses |
251,462,285.85 |
| Deferred Income Tax Assets |
542,425,315.39 |
| Other Non-Current Assets |
26,063,349.80 |
| Sub-Total of Non-Current Assets |
5,304,156,848.83 |
| Total Assets |
9,186,259,104.62 |
| Short-Term Loans |
1,650,340,583.95 |
| Trading Financial liabilities |
2,945,700.00 |
| Notes Payable |
10,000,000.00 |
| Accounts Payable |
1,258,543,750.26 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
87,413,955.92 |
| Taxes Payable |
62,395,584.21 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
205,662,701.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
533,139,556.97 |
| Other Current Liabilities |
5,127,703.82 |
| Sub-Total of Current Liabilities |
3,918,728,736.65 |
| Long-term Loans |
405,616,689.99 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
64,989,669.08 |
| Special Payable |
-- |
| Estimatied Liabilities |
118,702,442.39 |
| Deferred Income Tax Liabilities |
374,482,512.27 |
| Other Non-Current Liabilities |
2,061,510.00 |
| Sub-Total of Non-Current Liabilities |
2,182,881,575.33 |
| Total Liabilities |
6,101,610,311.98 |
| Paid-In Capital(Or Share Stock) |
485,299,039.00 |
| Capital Surplus |
1,790,715,439.87 |
| Surplus Reserve |
176,137,450.19 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
725,365,838.27 |
| Minority Stockholder's Interest |
80,592,123.47 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,004,056,669.17 |
| Owner's Equity（Stockholder's Equity） |
3,084,648,792.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,186,259,104.62 |
